Additional Key Data Updates from ASH 2022 on Treatment of LBCL


Experts highlight additional data updates from the ASH 2022 annual meeting regarding the treatment of patients with LBCL.

Related Videos
Tatyana Feldman, MD
Rahul Banerjee, MD, FACP, assistant professor, Clinical Research Division, Fred Hutchinson Cancer Center; assistant professor, Division of Hematology and Oncology, University of Washington